Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency

PURPOSE: Dihydropyrimidine dehydrogenase (DPD) deficiency can lead to severe toxicity in patients treated with standard doses of 5-fluorouracil (5-FU). Oral uracil administration and subsequent measurement of uracil and dihydrouracil (DHU) plasma concentrations might detect patients with DPD deficie...

Descripción completa

Detalles Bibliográficos
Autores principales: van Staveren, Maurice C., Theeuwes-Oonk, Barbara, Guchelaar, Henk Jan, van Kuilenburg, André B. P., Maring, Jan Gerard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220818/
https://www.ncbi.nlm.nih.gov/pubmed/21590448
http://dx.doi.org/10.1007/s00280-011-1661-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220818/
https://www.ncbi.nlm.nih.gov/pubmed/21590448
http://dx.doi.org/10.1007/s00280-011-1661-5

Ejemplares similares